ConductScience.org, home

Gene · 1308

COL17A1: collagen type XVII alpha 1 chain

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. COL17A1: collagen type XVII alpha 1 chain. Genes, record 1308. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1308

On this page

Gene

Symbol
COL17A1
HGNC
Name
collagen type XVII alpha 1 chain
HGNC
NCBI Gene ID
1308
NCBI Gene
HGNC ID
HGNC:2194
HGNC
Ensembl
ENSG00000065618
NCBI Gene
Aliases
BA16H23.2, BP180, BPA-2, BPAG2, ERED, JEB4, LAD-1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UMD9Collagen alpha-1(XVII) chain1,4971Ensembl, GeneID, HGNC

Source UniProt

Patents41

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026042028 A2026-03-1021Q9UMD9Espacenet
EP 4703376 A12026-03-0490Q9UMD9Espacenet
EP 4641201 A22025-10-2925419Q9UMD9Espacenet
US 12428468 B22025-09-309Q9UMD9Espacenet
US 12428469 B22025-09-309Q9UMD9Espacenet
JP 2025529142 A2025-09-041078Q9UMD9Espacenet
US 12371689 B22025-07-291078Q9UMD9Espacenet
JP 2025517969 A2025-06-1225419Q9UMD9Espacenet
JP 2024167302 A2024-12-0321Q9UMD9Espacenet
US 12128122 B22024-10-2921Q9UMD9Espacenet

1 to 10 of 41

See all 41 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants824

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCOL17A1 papersNewest fiscal year
P30CA008748Cancer Center Support Grant112025
UL1TR001863Yale Clinical and Translational Science Award62025
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center42025
P30ES010126UNC Center for Environmental Health and Susceptibility42025
P30AR075047Skin Biology Resource-Based Center at UCI32025
P30CA016672Cancer Center Support Grant32025
R01AR043799Mechanisms of Epidermal Homeostasis and Early Neoplasia32025
R01AR063070Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa32025
P30AR069589Penn Skin Biology and Diseases Resource-based Center22025
P30CA016086Cancer Center Support Grant22025

1 to 10 of 824Source NIH's project files

See all 824 nih grants

Papers3,031

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa.Mol Ther Nucleic Acids202642824587PubTator, text miningPubMed
Exacerbation of Bullous Pemphigoid following a Closed Bone Fracture in an Elderly Patient: A Case Report.Case Rep Dermatol202642820212PubTator, text miningPubMed
Six Cases of Pemphigoid Nodularis during Treatment with Dipeptidyl Peptidase-4 Inhibitors.Case Rep Dermatol202642813148PubTator, text miningPubMed
Clinical remission despite persistent anti-BP180 antibodies in neonatal pemphigoid.J Eur Acad Dermatol Venereol202642808694PubTator, text miningPubMed
Blistering rash in an elderly patient.J Hosp Med202642803220PubTator, text miningPubMed
Coexistence of Erythrodermic Psoriasis and Bullous Pemphigoid: A Case Report.Clin Cosmet Investig Dermatol202642770037PubTator, text miningPubMed
Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.IJU Case Rep202642688408PubTator, text miningPubMed
Repositioning omalizumab in dermatology: emerging indications and mechanism-based therapeutic insights.Expert Opin Biol Ther202642664019PubTator, text miningPubMed
Dupilumab enables glucocorticoid withdrawal in refractory multisite mucous membrane pemphigoid: a case report.Front Med (Lausanne)202642656375PubTator, text miningPubMed
Transcriptomic Profiling Identifies a Subset of Renal Tumors with Overlapping Features of Clear Cell Papillary Renal Cell Tumor and Renal Cell Carcinoma with Fibromyomatous Stroma.Cancers (Basel)202642650024PubTator, text miningPubMed

1 to 10 of 3,031

See all 3,031 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1308

GET https://conductscience.org/api/genes/v1/1308/patents?page=2